Innovent Biologics, Inc. (HKG:1801)

Hong Kong · Delayed Price · Currency is HKD

98.05

+2.15 (2.24%)

Sep 30, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biotechnology	13.04B	9.42B	6.21B	4.56B	4.27B
Total	13.04B	9.42B	6.21B	4.56B	4.27B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
The People's Republic of China (PRC)	12.07B	8.98B	5.75B	4.13B	3.97B
United States of America ("USA")	380.61M	411.59M	442.60M	411.03M	261.64M
Europe	571.81M	-	-	-	-
Other	19.63M	26.88M	10.12M	12.81M	-
Republic of Indonesia	-	-	-	-	6.60M
Republic of France	-	-	-	-	33.97M
Total	13.04B	9.42B	6.21B	4.56B	4.27B